Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.060
-0.010 (-0.93%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.14 million as of July 24, 2026. Its market cap has decreased by -12.63% in one year.
Market Cap
4.14M
Enterprise Value
-9.21M
1-Year Change
-12.63%
Ranking
Category
Stock Price
$1.06
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.14M, a decrease of -95.42%. That is a compound annual growth rate of -41.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 4.14M | -12.56% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 4.90M |
| Cardio Diagnostics Holdings | 4.90M |
| Alzamend Neuro | 4.79M |
| Alaunos Therapeutics | 4.72M |
| Enveric Biosciences | 4.71M |
| Mustang Bio | 4.40M |
| PMGC Holdings | 4.20M |
| Ensysce Biosciences | 4.06M |